Literature DB >> 21744797

Analysis of chloroquine resistance transporter (CRT) isoforms and orthologues in S. cerevisiae yeast.

Nicholas K Baro1, Chaya Pooput, Paul D Roepe.   

Abstract

Previous work from our laboratory optimized MeOH-inducible expression of the P. falciparum malarial parasite transporter PfCRT in P. pastoris yeast. These strains are useful for many experiments but do not allow for inducible protein expression under ambient growth conditions. We have therefore optimized galactose-inducible expression of PfCRT in S. cerevisiae yeast. We find that expression of PfCRT confers CQ hypersensitivity to growing yeast and that this is due to plasma membrane localization of the transporter. We use quantitative analyses of growth rates to compare hypersensitivity for yeast expressing various PfCRT isoforms. We also report successful high level inducible expression of the P. vivax orthologue, PvCRT, and compare CQ hypersensitivity for PvCRT vs PfCRT expressing yeast. We test the hypothesis that hypersensitivity is due to increased transport of CQ into yeast expressing the transporters via direct (3)H-CQ transport experiments and analyze the effect that membrane potential has on transport. The data suggest important new tools for rapid functional screening of PfCRT and PvCRT isoforms and provide further evidence for a model wherein membrane potential promotes charged CQ transport by PfCRT. Data also support our previous conclusion that wild type PfCRT is capable of CQ transport and provide a basis for understanding the lack of correspondence between PvCRT mutations and resistance to CQ in the important malarial parasite P. vivax.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744797      PMCID: PMC3155940          DOI: 10.1021/bi200922g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum.

Authors:  Roland A Cooper; Michael T Ferdig; Xin-Zhuan Su; Lyann M B Ursos; Jianbing Mu; Takashi Nomura; Hisashi Fujioka; David A Fidock; Paul D Roepe; Thomas E Wellems
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

3.  Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.

Authors:  Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

4.  PfNT2, a permease of the equilibrative nucleoside transporter family in the endoplasmic reticulum of Plasmodium falciparum.

Authors:  Megan J Downie; Kamal El Bissati; April M Bobenchik; Laura Nic Lochlainn; Alexander Amerik; Rachel Zufferey; Kiaran Kirk; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

5.  Characterization of genes that are synthetically lethal with ade3 or leu2 in Saccharomyces cerevisiae.

Authors:  Shraddha S Nigavekar; John F Cannon
Journal:  Yeast       Date:  2002-01-30       Impact factor: 3.239

Review 6.  PfCRT-mediated drug transport in malarial parasites.

Authors:  Paul D Roepe
Journal:  Biochemistry       Date:  2010-12-22       Impact factor: 3.162

7.  Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross.

Authors:  Jigar J Patel; Drew Thacker; John C Tan; Perri Pleeter; Lisa Checkley; Joseph M Gonzales; Bingbing Deng; Paul D Roepe; Roland A Cooper; Michael T Ferdig
Journal:  Mol Microbiol       Date:  2010-09-29       Impact factor: 3.501

8.  Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria.

Authors:  T Nomura; J M Carlton; J K Baird; H A del Portillo; D J Fryauff; D Rathore; D A Fidock; X Su ; W E Collins; T F McCutchan; J C Wootton; T E Wellems
Journal:  J Infect Dis       Date:  2001-04-27       Impact factor: 5.226

9.  Reduced digestive vacuolar accumulation of chloroquine is not linked to resistance to chloroquine toxicity.

Authors:  Mynthia Cabrera; Michelle F Paguio; Changan Xie; Paul D Roepe
Journal:  Biochemistry       Date:  2009-12-01       Impact factor: 3.162

10.  Analysis of the antimalarial drug resistance protein Pfcrt expressed in yeast.

Authors:  Hanbang Zhang; Ellen M Howard; Paul D Roepe
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

View more
  17 in total

1.  Degrees of chloroquine resistance in Plasmodium - is the redox system involved?

Authors:  Adele M Lehane; Christopher A McDevitt; Kiaran Kirk; David A Fidock
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-12-01       Impact factor: 4.077

2.  Signaling of chloroquine-induced stress in the yeast Saccharomyces cerevisiae requires the Hog1 and Slt2 mitogen-activated protein kinase pathways.

Authors:  Shivani Baranwal; Gajendra Kumar Azad; Vikash Singh; Raghuvir S Tomar
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

Review 3.  PfCRT and its role in antimalarial drug resistance.

Authors:  Andrea Ecker; Adele M Lehane; Jérôme Clain; David A Fidock
Journal:  Trends Parasitol       Date:  2012-09-25

4.  Tricks in Plasmodium's molecular repertoire--escaping 3'UTR excision-based conditional silencing of the chloroquine resistance transporter gene.

Authors:  Andrea Ecker; Rebecca E Lewis; Eric H Ekland; Bamini Jayabalasingham; David A Fidock
Journal:  Int J Parasitol       Date:  2012-09-27       Impact factor: 3.981

5.  Deciphering the Resistance-Counteracting Functions of Ferroquine in Plasmodium falciparum-Infected Erythrocytes.

Authors:  Faustine Dubar; Sylvain Bohic; Daniel Dive; Yann Guérardel; Peter Cloetens; Jamal Khalife; Christophe Biot
Journal:  ACS Med Chem Lett       Date:  2012-04-13       Impact factor: 4.345

6.  Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).

Authors:  Paul S Callaghan; Matthew R Hassett; Paul D Roepe
Journal:  Biochemistry       Date:  2015-08-06       Impact factor: 3.162

7.  Function of resistance conferring Plasmodium falciparum chloroquine resistance transporter isoforms.

Authors:  Nicholas K Baro; Paul S Callaghan; Paul D Roepe
Journal:  Biochemistry       Date:  2013-06-06       Impact factor: 3.162

8.  Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum.

Authors:  Yoann Augagneur; Lise Jaubert; Matthieu Schiavoni; Niseema Pachikara; Aprajita Garg; Sahar Usmani-Brown; Donna Wesolowski; Skye Zeller; Abhisek Ghosal; Emmanuel Cornillot; Hamid M Said; Priti Kumar; Sidney Altman; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

9.  Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesicles.

Authors:  Janni Papakrivos; Juliana M Sá; Thomas E Wellems
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

10.  Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.

Authors:  Sarah Heckmatt Shafik; Sashika Natasha Richards; Ben Corry; Rowena Elizabeth Martin
Journal:  PLoS Biol       Date:  2022-05-04       Impact factor: 9.593

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.